Montelukast-induced adverse drug reactions: A review of case reports in the literature

Pharmacology

Volumn 94, Issue , 2014, Pages 60-70

  Calapai, Gioacchino ^b   Casciaro, Marco ^a   Miroddi, Marco ^b   Calapai, Fabrizio ^b   Navarra, Michele ^c   Gangemi, Sebastiano ^a,d  

^a Division of Allergology and Clinical Immunology   (Mexico)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d CNR   (Italy)

Author keywords

Adverse drug reaction; Allergy; Anti leucotrienes; Asthma; Churg Strauss syndrome; Hypersensitivity; Montelukast; Pharmacovigilance; Toxicity

Indexed keywords

MONTELUKAST; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ADVERSE DRUG REACTION; AGITATION; ANGIONEUROTIC EDEMA; ANXIETY; AUTOIMMUNE DISEASE; BEHAVIOR DISORDER; CHURG STRAUSS SYNDROME; DEPRESSION; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ERYTHEMA NODOSUM; HALLUCINATION; HEMATURIA; HUMAN; HYPERTRANSAMINASEMIA; HYPERTRIGLYCERIDEMIA; NEUROPATHY; PANCREAS DISEASE; PRURITUS; REVIEW; SEIZURE; SKIN BRUISING; SLEEP DISORDER; SUICIDAL IDEATION; TREMOR; URTICARIA; VASCULITIS; ADULT; ASTHMA; CHILD; RISK FACTOR;

ACETATES; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; HUMANS; LEUKOTRIENE ANTAGONISTS; QUINOLINES; RISK FACTORS;

EID: 84908592696     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000366164     Document Type: Review

References (69)

1. Peters-Golden M, Gleason MM, Togias A: Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 2006; 36: 689-703.
2. Fal AM, Kopec A: Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment (in Polish). Pneumonol Alergol Pol 2010; 78: 68-73.
3. Shirasaki H, Kanaizumi E, Seki N, Fujita M, Kikuchi M, Himi T: Localization and up-regulation of cysteinyl leukotriene-2 receptor in human allergic nasal mucosa. Allergol Int 2013; 62: 223-228.
4. Kanda T, Tanio H, Wu C, Nishihara H, Nogaki F, Ono T: Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist. Clin Exp Nephrol 2010; 14: 602-607.
5. Sircar G, Saha B, Bhattacharya SG, Saha S: Allergic asthma biomarkers using systems approaches. Front Genet 2014; 4: 308.
6. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478.
7. Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A: Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008; 63: 453-462.
8. Haselkorn T, Chen H, Miller DP, Fish JE, Peters SP, Weiss ST, Jones CA: Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) study. Ann Allergy Asthma Immunol 2010; 104: 471-477.
9. Bozek A, Jarzab J: Adherence to asthma therapy in elderly patients. J Asthma 2010; 47: 162-165.
10. Keith PK, Koch C, Djandji M, Bouchard J, Psaradellis E, Sampalis JS, Schellenberg RR, McIvor RA: Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J 2009; 16(suppl A):17A-31A.
11. Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, Knorr B, Noonan G: Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol 2009; 44: 568-579.
12. Kroegel C: Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol 2009; 5: 239-249.
13. Chauhan BF, Ben Salah R, Ducharme FM: Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma. Cochrane Database Syst Rev 2013; 10:CD009585.
14. Chauhan BF, Ducharme FM: Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/ or chronic asthma in adults and children. Cochrane Database Syst Rev 2012; 5: CD002314.
15. Pagnoux C: Churg-Strauss syndrome: evolving concepts. Discov Med 2010; 9: 243-252.
16. Camargo CA Jr, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, Legrand C, Dass SB, Knorr BA, Reiss TF: A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010; 125: 374-380.
17. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P: Churg-Strauss syndrome. Clinical study and long-term followup of 96 patients. Medicine (Baltimore) 1999; 78: 26-37.
18. Bibby S, Healy B, Steele R, Kumareswaran K, Nelson H, Beasley R: Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database. Thorax 2010; 65: 132-138.
19. Villena V, Hidalgo R, Sotelo MT, Martin-Escribano P: Montelukast and Churg-Strauss syndrome. Eur Respir J 2000; 15: 626.
20. Goransson LG, Omdal R: A severe systemic inflammatory reaction following therapy with montelukast (Singulair). Nephrol Dial Transplant 2000; 15: 1054-1055.
21. Solans R, Bosch J, Selva A, Orriols R, Vilardell M: Montelukast and Churg-Strauss syndrome. Thorax 2002; 57: 183-185.
22. Michael AB, Murphy D: Montelukast-associated Churg-Strauss syndrome. Age Ageing 2003; 32: 551-552.
23. Cuchacovich R, Justiniano M, Espinoza LR: Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA). Clin Rheumatol 2007; 26: 1769-1771.
24. Currie GP, McKinlay L, Kerr KM: Histological appearances of putative montelukast related Churg-Strauss syndrome. Thorax 2008; 63: 1120.
25. Girszyn N, Amiot N, Lahaxe L, Cuvelier A, Courville P, Marie I: Churg-Strauss syndrome associated with montelukast therapy. QJM 2008; 101: 669-671.
26. Jennings L, Ho WL, Gulmann C, Murphy GM: Churg-Strauss syndrome secondary to antileucotriene therapy in a patient not receiving oral corticosteroids. Clin Exp Dermatol 2009; 34:e430-e431.
27. Man MA, Alexandrescu D, Pop M, Trofor A: Churg Strauss syndrome associated with montelukast-case report. Pneumologia 2012; 61: 113-116.
28. Wechsler ME, Finn D, Gunawardena D, Westlake R, Barker A, Haranath SP, Pauwels RA, Kips JC, Drazen JM: Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest Journal 2000; 117: 708-713.
29. Matsui K, Nishijima K: A case of montelukast-induced Churg-Strauss syndrome associated with liver dysfunction. Case Reports in Hepatology 2011, DOI: dx.doi.org/10.1155/2011/412524.
30. Anar C, Unsal I, Ozanturk ME, Halilcolar H, Yucel N: A case of Churg-Strauss syndrome treated with montelukast. Med Princ Pract 2012; 21: 186-189.
31. Franco J, Artes MJ: Pulmonary eosinophilia associated with montelukast. Thorax 1999; 54: 558-560.
32. Tuggey JM, Hosker HS: Churg-Strauss syndrome associated with montelukast therapy. Thorax 2000; 55: 805-806.
33. Carlesimo M, Mari E, Palese E, Pranteda G, Camplone G: Churg-Strauss and montelukast. Int J Immunopathol Pharmacol 2011; 24: 1079-1082.
34. Black JG, Bonner JR, Boulware D, Andea AA: Montelukast-associated Churg-Strauss vasculitis: another associated report. Ann Allergy Asthma Immunol 2009; 102: 351-352.
35. Conen D, Leuppi J, Bubendorf L, Ronsdorf A, Tamm M, Hauser T: Montelukast and Churg-Strauss syndrome. Swiss Med Wkly 2004; 134: 377-380.
36. Zandman-Goddard G, Sylantiev C, Langevitz P: Montelukast-related Churg-Strauss vasculitis presenting with peripheral neuropathy. Isr Med Assoc J 2007; 9: 50-51.
37. Guilpain P, Viallard JF, Lagarde P, Cohen P, Kambouchner M, Pellegrin JL, Guillevin L: Churg-Strauss syndrome in two patients receiving montelukast. Rheumatology 2002; 41: 535-539.
38. Mukhopadhyay A, Stanley NN: Churg-Strauss syndrome associated with montelukast. Postgrad Med J 2001; 77: 390-391.
39. Uyar M, Elbek O, Bakir K, Kibar Y, Bayram N, Dikensoy O: Churg-Strauss syndrome related to montelukast. Tuberk Toraks 2012; 60: 56-58.
40. Manalai P, Woo JM, Postolache TT: Suicidality and montelukast. Expert Opin Drug Saf 2009; 8: 273-282.
41. Philip G, Hustad C, Noonan G, Malice MP, Ezekowitz A, Reiss TF, Knorr B: Reports of suicidality in clinical trials of montelukast. J Allergy Clin Immunol 2009; 124: 691-696.e6.
42. Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA: Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study. J Allergy Clin Immunol 2012; 130: 368-375.
43. Wallerstedt SM, Brunlof G, Sundstrom A, Eriksson AL: Montelukast and psychiatric disorders in children. Pharmacoepidemiol Drug Saf 2009; 18: 858-864.
44. Anandan N, Ibitoye F: Montelukast and worsening of hallucinations in paranoid schizophrenia. Psychiatric Bulletin 2008; 32: 276-276.
45. Ibarra-Barrueta O, Palacios-Zabalza I, Mora-Atorrasagasti O, Mayo-Suarez J: Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events. Ann Pharmacother 2014; 48: 145-148.
46. Cereza G, Garcia Dolade N, Laporte JR: Nightmares induced by montelukast in children and adults. Eur Respir J 2012; 40: 1574-1575.
47. Callero-Viera A, Infante S, Fuentes-Aparicio V, Zapatero L, Alonso-Lebrero E: Neuropsychiatric reactions to montelukast. J Investig Allergol Clin Immunol 2012; 22: 452-453.
48. Byrne F, Oluwole B, Whyte V, Fahy S, Mc-Guinness D: Delayed onset of neuropsychiatric effects associated with montelukast. Ir J Psych Med 2012; 29: 125-127.
49. Kocyigit A, Gulcan Oksuz B, Yarar F, Uzun F, Igde M, Islek I: Hallucination development with montelukast in a child with asthma: case presentation. Iran J Allergy Asthma Immunol 2013; 12: 397-399.
50. Alkhuja S, Gazizov N, Alexander ME: Sleeptalking! Sleepwalking! Side effects of montelukast. Case Rep Pulmonol 2013; 2013: 813786.
51. Palodhi S, Ray Chaudhuri P, Biswas A, Bera T: Montelukast induced hypertriglyceridemia. Indian Med Gaz 2012; 146: 334-336.
52. Harugeri A, Parthasarathi G, Sharma J, D'Souza GA, Ramesh M: Montelukast induced acute hepatocellular liver injury. J Postgrad Med 2009; 55: 141-142.
53. Russmann S, Iselin HU, Meier D, Zimmermann A, Simon HU, Caduff P, Reichen J: Acute hepatitis associated with montelukast. J Hepatol 2003; 38: 694-695.
54. Incecik F, Onlen Y, Sangun O, Akoglu S: Probable montelukast-induced hepatotoxicity in a pediatric patient: case report. Ann Saudi Med 2007; 27: 462-463.
55. Actis GC, Bugianesi E, Ottobrelli A, Rizzetto M: Fatal liver failure following food supplements during chronic treatment with montelukast. Dig Liver Dis 2007; 39: 953-955.
56. Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK: A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis. J Young Pharm 2013; 5: 64-66.
57. Cetkovska P, Pizinger K: Childhood pemphigus associated with montelukast administration. Clin Exp Dermatol 2003; 28: 328-329.
58. Minciullo PL, Saija A, Bonanno D, Ferlazzo E, Gangemi S: Montelukast-induced generalized urticaria. Ann Pharmacother 2004; 38: 999-1001.
59. Tedeschi A: Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast. Eur Ann Allergy Clin Immunol 2009; 41: 187-189.
60. Herzinger T, Ludolph-Hauser D, Przybilla B: Urticaria triggered by antiallergy treatment. Clin Exp Dermatol 2008; 33: 519-520.
61. Sabbagh R, Sheikh-Taha M: Possible montelukast-induced angioedema. Am J Health Syst Pharm 2009; 66: 1705-1706.
62. Aypak C, Turedi O, Solmaz N, Yikilkan H, Gorpelioglu S: A rare adverse effect of montelukast treatment: ecchymosis. Respir Care 2013; 58:e104-e106.
63. Tayeb MMS: Allergy to montelukast sodium treated effectively by protracted oral desensitization: first case report. J Aller Ther 2013; 4: 2.
64. Xie JX, Wei JF, Meng L: Montelukast sodiuminduced hematuria: a case report and literature review of 19 cases in mainland China. Int J Clin Pharmacol Ther 2013; 51: 958-962.
65. Ducharme FM, Lasserson TJ, Cates CJ: Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev 2011:CD003137.
66. Scichilone N, Battaglia S, Benfante A, Bellia V: Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients. Clin Interv Aging 2013; 8: 1329-1337.
67. Singh RK, Tandon R, Dastidar SG, Ray A: A review on leukotrienes and their receptors with reference to asthma. J Asthma 2013; 50: 922-931.
68. Ding Q, Fang SH, Zhou Y, Zhang LH, Zhang WP, Chen Z, Wei EQ: Cysteinyl leukotriene receptor 1 partially mediates brain cryoinjury in mice. Acta Pharmacol Sin 2007; 28: 945-952.
69. Cuciureanu M, Cəruntu ID, Pəduraru O, Stoica B, Jerca L, Crauciuc E, Nechifor M: The protective effect of montelukast sodium on carbon tetrachloride induced hepatopathy in rat. Prostaglandins Other Lipid Mediat 2009; 88: 82-88.